Biotech Clinuvel Pharmaceuticals now expanding UV research
MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to $27.83 this
MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to $27.83 this
FEATURED
Property group reveals revised mixed-use housing development plans
Best retirement housing design for Global Awards shortlisted
Vision for affordable and sustainable multigenerational housing canvassed by experts
Intergenerational social housing boom in particular now underway
Study pinpoints mealtime issues in nursing home residents with dementia
Nursing home ownership moves represent major risk to future survival of sector
INNOVATION
